Albrecht Jennifer S, Khokhar Bilal, Pradel Françoise, Campbell Michelle, Palmer Jacqueline, Harris Ilene, Palumbo Francis
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Maryland, USA.
Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy.
J Pharm Health Serv Res. 2015 Sep;6(3):139-144. doi: 10.1111/jphs.12099. Epub 2015 Jun 16.
Use of patient provider agreements (PPAs) is increasing, yet there is limited evidence on the effectiveness of PPAs to prevent prescription opioid misuse and diversion, and few guidelines for providers. We conducted eight focus groups to understand patient and prescriber perceptions of PPAs.
We recruited 40 patients who had been asked to sign a PPA and 40 prescribers who had administered at least one PPA. We developed topic guides for the two groups based on prior literature. Focus groups were audio-recorded and transcribed verbatim. Two investigators independently performed the content analysis of the transcripts and reached consensus on recurring themes.
PPA use varied according to physician specialty. General practitioners used PPAs the least but reported increasing pressure from liability insurers to use them. Many patients reported signing a PPA in the emergency room of a hospital. Prescribers and patients reported a lack of understanding among patients concerning the purpose and content of the PPA. Prescribers questioned the legal status of the PPA, while patients believed that the PPA was a legal document intended to protect prescribers. Patients and prescribers valued PPA content items differently, although both groups agreed that signing a PPA would not prevent opioid misuse.
We identified several themes concerning the administration, content, effectiveness and utility of PPAs that highlight areas of research to improve PPAs. We also describe trends requiring further investigation. Understanding content of importance to patients will facilitate the development of a patient-centred PPA.
患者与医疗服务提供者协议(PPA)的使用正在增加,但关于PPA预防处方阿片类药物滥用和转移有效性的证据有限,且针对医疗服务提供者的指南也很少。我们开展了8个焦点小组讨论,以了解患者和开处方者对PPA的看法。
我们招募了40名被要求签署PPA的患者和40名至少开具过一份PPA的开处方者。我们根据先前的文献为两组制定了主题指南。焦点小组讨论进行了录音,并逐字转录。两名研究人员独立对转录内容进行了内容分析,并就反复出现的主题达成了共识。
PPA的使用因医生专业而异。全科医生使用PPA最少,但报告称来自责任保险公司要求使用PPA的压力在增加。许多患者报告在医院急诊室签署了PPA。开处方者和患者都报告称患者对PPA的目的和内容缺乏了解。开处方者质疑PPA的法律地位,而患者认为PPA是一份旨在保护开处方者的法律文件。患者和开处方者对PPA内容项目的重视程度不同,尽管两组都认为签署PPA并不能防止阿片类药物滥用。
我们确定了几个关于PPA的管理、内容、有效性和实用性的主题,这些主题突出了需要改进PPA的研究领域。我们还描述了需要进一步调查的趋势。了解对患者重要的内容将有助于制定以患者为中心的PPA。